20 /100
LOW RISK
Score updated Jul 13, 2026

SRAD — Sportradar Group AG Dilution Risk Tracker

Track SRAD dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track SRAD — Get alerts when the score changes →

As of July 13, 2026, Sportradar Group AG (SRAD) has a DilutionWatch DilutionScore of 20/100, rated LOW dilution risk. Sportradar Group AG has a market capitalization of $3.91B, 217.45M shares outstanding, 161 institutional holders tracked.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
25
📊 Float Risk
17
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for SRAD.
🔔 Track SRAD — Get forecast alerts →

💹 Market Data

Market Cap$3.91B
Shares Outstanding217.45M
Float147.02M
Cash$375.17M
Debt$71.84M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 4.1% shares (2026Q1 vs prior)
161 institutional holders · 202.82M shares
#1 CANADA PENSION PLAN INVESTMENT BOARD 68.17M shares
#2 Technology Crossover Management IX, Ltd. 29.20M shares
#3 Radcliff Management LLC 13.13M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest11.34M
Days to Cover5.6
% of Float7.7%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

No recent SEC insights

📰 Recent News

No recent news

📋 What This Means for SRAD Shareholders

Sportradar Group AG (SRAD) has a DilutionScore of 20/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 13, 2026.

DilutionWatch's EDGAR monitoring for SRAD shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for SRAD in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for SRAD alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track SRAD Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking SRAD — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for SRAD
📊 SRAD FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 SRAD Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.